American International Group’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
BOCH
American International Group's LRMR Position: Q2 2024 in Review
American International Group sold out of Larimar Therapeutics (LRMR) in Q2 2024, closing a stake of 12,825 shares — an estimated $97.3K sold.
American International Group first reported a position in LRMR in Q4 2014 and held it in 18 quarters. The position peaked at $335K in Q2 2015. 107 funds tracked by Wall St. Rank hold LRMR as of Q2 2024.
- American International Group reported no remaining Larimar Therapeutics position as of Q2 2024 after selling out during the quarter.
- American International Group sold 12,825 Larimar Therapeutics shares in Q2 2024, an estimated $97.3K.
- American International Group first reported a position in Larimar Therapeutics in Q4 2014 and held it in 18 quarters.
- American International Group's Larimar Therapeutics position peaked at $335K in Q2 2015.
- 107 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2024.
Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.